These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

507 related items for PubMed ID: 28939985

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Long non-coding RNA ATB promotes malignancy of esophageal squamous cell carcinoma by regulating miR-200b/Kindlin-2 axis.
    Li Z, Wu X, Gu L, Shen Q, Luo W, Deng C, Zhou Q, Chen X, Li Y, Lim Z, Wang X, Wang J, Yang X.
    Cell Death Dis; 2017 Jun 22; 8(6):e2888. PubMed ID: 28640252
    [Abstract] [Full Text] [Related]

  • 4. Ezrin Ser66 phosphorylation regulates invasion and metastasis of esophageal squamous cell carcinoma cells by mediating filopodia formation.
    Li LY, Xie YH, Xie YM, Liao LD, Xu XE, Zhang Q, Zeng FM, Tao LH, Xie WM, Xie JJ, Xu LY, Li EM.
    Int J Biochem Cell Biol; 2017 Jul 22; 88():162-171. PubMed ID: 28504189
    [Abstract] [Full Text] [Related]

  • 5. Long noncoding RNA SNHG12 induces proliferation, migration, epithelial-mesenchymal transition, and stemness of esophageal squamous cell carcinoma cells via post-transcriptional regulation of BMI1 and CTNNB1.
    Wu D, He X, Wang W, Hu X, Wang K, Wang M.
    Mol Oncol; 2020 Sep 22; 14(9):2332-2351. PubMed ID: 32239639
    [Abstract] [Full Text] [Related]

  • 6. SMYD3 stimulates EZR and LOXL2 transcription to enhance proliferation, migration, and invasion in esophageal squamous cell carcinoma.
    Zhu Y, Zhu MX, Zhang XD, Xu XE, Wu ZY, Liao LD, Li LY, Xie YM, Wu JY, Zou HY, Xie JJ, Li EM, Xu LY.
    Hum Pathol; 2016 Jun 22; 52():153-63. PubMed ID: 26980013
    [Abstract] [Full Text] [Related]

  • 7. miR‑378a‑3p exerts tumor suppressive function on the tumorigenesis of esophageal squamous cell carcinoma by targeting Rab10.
    Ding N, Sun X, Wang T, Huang L, Wen J, Zhou Y.
    Int J Mol Med; 2018 Jul 22; 42(1):381-391. PubMed ID: 29693138
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Silencing of Rab3D suppresses the proliferation and invasion of esophageal squamous cell carcinoma cells.
    Zhang J, Kong R, Sun L.
    Biomed Pharmacother; 2017 Jul 22; 91():402-407. PubMed ID: 28472755
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Tumor Cell-Derived Complement Component C1r Acts as a Prognostic Biomarker and Promotes Esophageal Squamous Cell Carcinoma Progression.
    Tang M, Zhao S, Ren L, Li Q, Li L, Wang C, Meng C, Chen Y, Hu W.
    Front Biosci (Landmark Ed); 2024 Apr 02; 29(4):138. PubMed ID: 38682192
    [Abstract] [Full Text] [Related]

  • 13. SOX12 contributes to the activation of the JAK2/STAT3 pathway and malignant transformation of esophageal squamous cell carcinoma.
    Li C, Zhu M, Zhu J, Lu Q, Shi B, Sun B, Chen H.
    Oncol Rep; 2021 Jan 02; 45(1):129-138. PubMed ID: 33416144
    [Abstract] [Full Text] [Related]

  • 14. BACH1 promotes the progression of esophageal squamous cell carcinoma by inducing the epithelial-mesenchymal transition and angiogenesis.
    Zhao Y, Gao J, Xie X, Nan P, Liu F, Sun Y, Zhao X.
    Cancer Med; 2021 May 02; 10(10):3413-3426. PubMed ID: 33932125
    [Abstract] [Full Text] [Related]

  • 15. Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma.
    Gao Y, Yi J, Zhang K, Bai F, Feng B, Wang R, Chu X, Chen L, Song H.
    J Exp Clin Cancer Res; 2017 Nov 16; 36(1):161. PubMed ID: 29145896
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Expression and role of anion exchanger 1 in esophageal squamous cell carcinoma.
    Shiozaki A, Kudou M, Ichikawa D, Shimizu H, Arita T, Kosuga T, Konishi H, Komatsu S, Fujiwara H, Okamoto K, Kishimoto M, Marunaka Y, Otsuji E.
    Oncotarget; 2017 Mar 14; 8(11):17921-17935. PubMed ID: 28160546
    [Abstract] [Full Text] [Related]

  • 19. DCLK1 inhibition attenuates tumorigenesis and improves chemosensitivity in esophageal squamous cell carcinoma by inhibiting β-catenin/c-Myc signaling.
    Zhang L, Zhou S, Guo E, Chen X, Yang J, Li X.
    Pflugers Arch; 2020 Aug 14; 472(8):1041-1049. PubMed ID: 32533239
    [Abstract] [Full Text] [Related]

  • 20. High expression of Collagen Triple Helix Repeat Containing 1 (CTHRC1) facilitates progression of oesophageal squamous cell carcinoma through MAPK/MEK/ERK/FRA-1 activation.
    Wang C, Li Z, Shao F, Yang X, Feng X, Shi S, Gao Y, He J.
    J Exp Clin Cancer Res; 2017 Jun 23; 36(1):84. PubMed ID: 28645305
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.